Skip to content

Quick ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.1×0.0×
Amgen logo
AmgenAMGN
+0.1×
Altimmune logo
AltimmuneALT
29.6×+13.7×
Viking Therapeutics logo
Viking TherapeuticsVKTX
5.7×-38.5×
Wave Life Sciences logo
Wave Life SciencesWVE
11.3×+8.3×
Prime Medicine logo
Prime MedicinePRME
3.8×-1.0×

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Calculated from Vivani Medical’s reported figures.

Based on the most recent quarter.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's quick ratio?
Vivani Medical (VANI) reported quick ratio of 3.2× in Q1 2026.
How has Vivani Medical's quick ratio changed year-over-year?
Vivani Medical's quick ratio increased by 32.8% year-over-year, from 2.4× to 3.2×.
What is the long-term trend for Vivani Medical's quick ratio?
Over 5 years (2020 to 2025), Vivani Medical's quick ratio has grown at a 24.9% compound annual growth rate (CAGR), from 0.9× to 2.7×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.